Technical Analysis for PHAT - Phathom Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 9.42 | -7.56% | -0.77 |
PHAT closed down 7.56 percent on Friday, May 31, 2024, on 1.4 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Jun 5
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Fell Below 200 DMA | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -7.56% |
| Alert | Time |
|---|---|
| 200 DMA Support | 2 days ago |
| Lower Bollinger Band Support | 2 days ago |
| Down 1 ATR | 2 days ago |
| Fell Below 200 DMA | 2 days ago |
| Down 5% | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/05/2024
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. It develops Vonoprazan, a potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Buffalo Grove, IL.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Acid Natural Sciences Medication Gastrointestinal Disorders Potassium Gastrointestinal Disease Tadataka Yamada
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Acid Natural Sciences Medication Gastrointestinal Disorders Potassium Gastrointestinal Disease Tadataka Yamada
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.0 |
| 52 Week Low | 6.065 |
| Average Volume | 687,672 |
| 200-Day Moving Average | 9.61 |
| 50-Day Moving Average | 10.14 |
| 20-Day Moving Average | 10.26 |
| 10-Day Moving Average | 10.33 |
| Average True Range | 0.71 |
| RSI (14) | 41.18 |
| ADX | 24.43 |
| +DI | 19.44 |
| -DI | 20.22 |
| Chandelier Exit (Long, 3 ATRs) | 9.11 |
| Chandelier Exit (Short, 3 ATRs) | 11.09 |
| Upper Bollinger Bands | 11.05 |
| Lower Bollinger Band | 9.48 |
| Percent B (%b) | -0.04 |
| BandWidth | 15.24 |
| MACD Line | 0.05 |
| MACD Signal Line | 0.14 |
| MACD Histogram | -0.09 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.22 | ||||
| Resistance 3 (R3) | 11.36 | 10.89 | 10.92 | ||
| Resistance 2 (R2) | 10.89 | 10.43 | 10.83 | 10.82 | |
| Resistance 1 (R1) | 10.16 | 10.15 | 9.93 | 10.02 | 10.72 |
| Pivot Point | 9.69 | 9.69 | 9.58 | 9.63 | 9.69 |
| Support 1 (S1) | 8.96 | 9.23 | 8.73 | 8.82 | 8.12 |
| Support 2 (S2) | 8.49 | 8.95 | 8.43 | 8.02 | |
| Support 3 (S3) | 7.76 | 8.49 | 7.92 | ||
| Support 4 (S4) | 7.62 |
